NY A 10467
in committeeRelates to investigating critical prescription drug pricing
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 10467 pass?
Not yet. NY A 10467 is in committee as of 2026-03-06 and has not come to a final vote. Latest recorded action (2026-03-06): REFERRED TO INSURANCE
What is NY A 10467 about?
Requires investigating of critical prescription drug pricing; provides for civil penalties and private actions for certain critical prescription drug pricing.
Who sponsors NY A 10467?
Alicia Hyndman is the primary sponsor of NY A 10467.
Description
Requires investigating of critical prescription drug pricing; provides for civil penalties and private actions for certain critical prescription drug pricing.
- Introduced
- —
- Latest action
- 2026-03-06 — REFERRED TO INSURANCE
- Bill type
- bill
- Last updated
- —
Sponsors
- Alicia Hyndmanprimary
Committees
Not provided by source.
Action timeline
2026-03-06
REFERRED TO INSURANCE
referral-committee
Versions
- A10467Compare
Documents
Votes
Not provided by source.
Related bills
- Prior session: S 7739not in this corpus
- Prior session: S 320not in this corpus
- Prior session: S 2387not in this corpus
- Companion bill: S 396
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 10467. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.